Cargando…

Platelet glutamate dehydrogenase activity and efficacy of antipsychotic therapy in patients with schizophrenia

BACKGROUND: Evaluation of possible relationship between platelet glutamate dehydrogenase (GDH) activity and mental state of schizophrenia patients after antipsychotic pharmacotherapy. METHODS: Patients (n = 50) with chronic paranoid schizophrenia (F20.0) initially in acute psychotic state were exami...

Descripción completa

Detalles Bibliográficos
Autores principales:	Savushkina, Olga K., Tereshkina, Elena B., Prokhorova, Tatiana A., Boksha, Irina S., Burminskii, Denis S., Vorobyeva, Elena A., Morozova, Margarita A., Burbaeva, Gulnur Sh.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Society of Medical Biochemists of Serbia, Belgrade 2020
Materias:	Original Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7282235/ https://www.ncbi.nlm.nih.gov/pubmed/32549778 http://dx.doi.org/10.2478/jomb-2019-0018

Ejemplares similares

Late onset schizophrenia and delusional disorder: activity of platelet energy, glutamate, and glutathione metabolizing enzymes
por: Pochueva, V., et al.
Publicado: (2022)

The difference in serum proteomes in schizophrenia and bipolar disorder
por: Smirnova, Liudmila, et al.
Publicado: (2019)

Metabolic Hormones in Schizophrenia Patients with Antipsychotic-Induced Metabolic Syndrome
por: Boiko, Anastasiia S., et al.
Publicado: (2022)

The assessment of self-stigmatization of patients with schizophrenia and complex approach to reduce it
por: Mitikhin, V., et al.
Publicado: (2023)

Cytokine Level Changes in Schizophrenia Patients with and without Metabolic Syndrome Treated with Atypical Antipsychotics
por: Boiko, Anastasiia S., et al.
Publicado: (2021)

The Influence of Antipsychotic Treatment on the Activity of Abzymes Targeting Myelin and Levels of Inflammation Markers in Patients with Schizophrenia
por: Kamaeva, Daria A., et al.
Publicado: (2023)

The Complex Mechanism of Glutamate Dehydrogenase in Insulin Secretion
por: Fahien, Leonard A., et al.
Publicado: (2011)

Effects of Antipsychotic Administration on Brain Glutamate in Schizophrenia: A Systematic Review of Longitudinal (1)H-MRS Studies
por: Egerton, Alice, et al.
Publicado: (2017)

Levels of Acylcarnitines and Branched-Chain Amino Acids in Antipsychotic-Treated Patients with Paranoid Schizophrenia with Metabolic Syndrome
por: Mednova, Irina A., et al.
Publicado: (2022)

Genetic Polymorphisms of 5-HT Receptors and Antipsychotic-Induced Metabolic Dysfunction in Patients with Schizophrenia
por: Paderina, Diana Z., et al.
Publicado: (2021)

Comparative effectiveness of antipsychotic drugs in schizophrenia
por: Stroup, T. Scott, et al.
Publicado: (2000)

Survey on schizophrenia treatment in Mexico: perception and antipsychotic prescription patterns
por: Apiquian, Rogelio, et al.
Publicado: (2004)

Beyond Dopamine: Glutamate as a Target for Future Antipsychotics
por: Sendt, Kyra-Verena, et al.
Publicado: (2012)

Antipsychotic treatment and cognitive function in patients with schizophrenia
por: Tumova, M. A., et al.
Publicado: (2023)

Oxoglutarate dehydrogenase complex controls glutamate-mediated neuronal death
por: Weidinger, Adelheid, et al.
Publicado: (2023)

Antipsychotic monotherapy and polypharmacy in the naturalistic treatment of schizophrenia with atypical antipsychotics
por: Faries, Douglas, et al.
Publicado: (2005)

Genetic Biomarkers of Antipsychotic-Induced Prolongation of the QT Interval in Patients with Schizophrenia
por: Vaiman, Elena E., et al.
Publicado: (2022)

Antipsychotic pharmacogenomics in first episode psychosis: a role for glutamate genes
por: Stevenson, J M, et al.
Publicado: (2016)

Glutamate Dehydrogenase Functions in Glutamic Acid Metabolism and Stress Resistance in Pyropia haitanensis
por: Li, Shuang, et al.
Publicado: (2021)

Antipsychotic medication for women with schizophrenia spectrum disorders
por: Brand, Bodyl A., et al.
Publicado: (2022)

Aminotransferase and glutamate dehydrogenase activities in lactobacilli and streptococci
por: Peralta, Guillermo Hugo, et al.
Publicado: (2016)

Allosteric regulation of glutamate dehydrogenase deamination activity
por: Bera, Soumen, et al.
Publicado: (2020)

Physiological Role of Glutamate Dehydrogenase in Cancer Cells
por: Moreno-Sánchez, Rafael, et al.
Publicado: (2020)

Glutamate dehydrogenase hyperinsulinism: mechanisms, diagnosis, and treatment
por: Zeng, Qiao, et al.
Publicado: (2023)

T192. THE GUT MICROBIOME IN SCHIZOPHRENIA AND ANTIPSYCHOTIC INDUCED METABOLIC DYSFUNCTION
por: Kanji, Sarah, et al.
Publicado: (2018)

PM527. Higher serum concentrations of tyrosine and glutamate in schizophrenia patients treated with clozapine, compared to in those treated with conventional antipsychotics
por: Melkersson, Kristina, et al.
Publicado: (2016)

Anterior Cingulate Cortex Glutamate Levels Are Related to Response to Initial Antipsychotic Treatment in Drug-Naive First-Episode Schizophrenia Patients
por: Li, Jinguang, et al.
Publicado: (2020)

Systematic review of the economic aspects of nonadherence to antipsychotic medication in patients with schizophrenia
por: Dilla, Tatiana, et al.
Publicado: (2013)

Language disturbances in schizophrenia: the relation with antipsychotic medication
por: de Boer, J. N., et al.
Publicado: (2020)

Anticonvulsant Drugs, Brain Glutamate Dehydrogenase Activity and Oxygen Consumption
por: Vega Rasgado, Lourdes A., et al.
Publicado: (2012)

S77. ROLE OF DOPAMINE AND GLUTAMATE TRANSPORTERS IN GENERATION OF ANTIPSYCHOTIC EFFICACY
por: Kruyer, Anna, et al.
Publicado: (2020)

Search for Human Lactate Dehydrogenase A Inhibitors Using Structure-Based Modeling
por: Nilov, D. K., et al.
Publicado: (2015)

A Legionella effector ADP-ribosyltransferase inactivates glutamate dehydrogenase
por: Black, Miles H., et al.
Publicado: (2021)

Cost of antipsychotic polypharmacy in the treatment of schizophrenia
por: Zhu, Baojin, et al.
Publicado: (2008)

The heterogeneity of antipsychotic response in the treatment of schizophrenia
por: Case, M., et al.
Publicado: (2011)

New atypical antipsychotics for schizophrenia: iloperidone
por: Caccia, Silvio, et al.
Publicado: (2010)

Osteoporosis Associated with Antipsychotic Treatment in Schizophrenia
por: Wu, Haishan, et al.
Publicado: (2013)

Antipsychotic agents: efficacy and safety in schizophrenia
por: de Araújo, Arão Nogueira, et al.
Publicado: (2012)

Polypharmacy Management of Antipsychotics in Patients with Schizophrenia
por: Kamei, Hiroyuki
Publicado: (2022)

Identification of New Structural Fragments for the Design of Lactate Dehydrogenase A Inhibitors
por: Nilov, D.K., et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_nt985ej11krja829cs11n4uqsf